kapi

Executive Summary The Kenya Association of Pharmaceutical Industry (KAPI) is a membership organization, established in the late 1960s, representing biopharmaceutical manufacturers (or their local representatives) that through research invent and develop medicines and technologies (e.g., Biopharmaceuticals, Vaccine Healthcare, Medical devices, Diagnostics) that significantly improve people’s lives. KAPI represents the industry voice and promotes efficiency in […]

Executive Summary The Kenya Association of Pharmaceutical Industry (KAPI) is a membership organization, established in the late 1960s, representing biopharmaceutical manufacturers (or their local representatives) that through research invent and develop medicines and technologies (e.g., Biopharmaceuticals, Vaccine Healthcare, Medical devices, Diagnostics) that significantly improve people’s lives. KAPI represents the industry voice and promotes efficiency in

On Tuesday 26th January 2021 the Kenya Association of Pharmaceutical Industry (KAPI) executive board led by the Chairperson, Willy Soriney paid a courtesy visit to the Principal Secretary, Ministry of Health Madam Susan Mochache. This was part of the associations’ stakeholder engagement mechanisms aimed at fostering collaborative spirit for the advancement of the health agenda for

In a day, we’ll be crossing over from a significantly life-changing year to the next. The year 2020 has been life-changing to all of us; work from home, masking, social distancing, job losses, and loss of loved ones among others. It’s been extraordinary how we’ve adapted to the changes, pivoted our systems to cope and

As a membership organization driven by tenets of social responsibility and commitment to public health, in the wake of COVID-19 it is in our purview to drive a common agenda to flatten the curve of transmission, build concerted efforts to ensure uninterrupted supply of medicines, diagnostics and healthcare technologies. Additionally, our member companies have been

Health experts have warned against arbitrary use of aspirin in managing high blood pressure. Responding to an emailed inquiry by this writer, Dr Loise Nyanjau of the Ministry of Health (MoH) said low-dose aspirin increases the risk of brain haemorrhage. Long regarded as a wonder drug in the management of heart diseases, it is emerging

The Kenya Association of Pharmaceutical Industry (KAPI) has expressed its commitment to continue facilitating a progressive reduction in the cost of Non communicable diseases (NCDs) medicines locally. In a swift response to a public call by President Uhuru Kenyatta to international pharmaceutical firms, to reduce the cost of NCD medicines, KAPI, has confirmed ongoing efforts

In 1897, a big ship docks in Mombasa from India. An Indian man gets off, stays a couple of years, finds Kenya too wild and gets on another ship and sails back to India. But the call of Africa doesn’t abate so he comes back in 1910, sets base and then invites some cousins over